Bioregenx (BRGX) Free Cash Flow (2022 - 2026)
Bioregenx's (BRGX) quarterly Free Cash Flow came in at $26629.0 in Q1 2026, down 29.36% year-on-year from $37695.0 in Q1 2025, and down 60.0% quarter-over-quarter from $66579.0 in Q4 2025.
Bioregenx (BRGX) Free Cash Flow (2022 - 2026) Analysis & Trends
Bioregenx's Free Cash Flow history runs 5 years deep, the most recent figure standing at $26629.0 for Q1 2026.
- On a quarterly basis, Free Cash Flow fell 29.36% year-over-year to $26629.0 in Q1 2026; TTM through Mar 2026 was $18849.0, a 110.35% increase from a year earlier, with the FY2025 full-year figure at $29915.0, up 105.83% from the prior year.
- Free Cash Flow declined to $26629.0 in Q1 2026 per BRGX's latest filing, from $66579.0 in the prior quarter.
- Across five years, Free Cash Flow topped out at $66579.0 in Q4 2025 and bottomed at -$649161.0 in Q2 2023.
- The 5-year median for Free Cash Flow is -$31196.0 (2024), against an average of -$119805.2.
- Across the five-year window, Free Cash Flow sank 5528.46% in 2023 and jumped 686.03% in 2025, its largest moves.
- Year by year, Free Cash Flow stood at -$4364.0 in 2022, then sank by 5528.46% to -$245626.0 in 2023, then jumped by 95.37% to -$11361.0 in 2024, then soared by 686.03% to $66579.0 in 2025, then sank by 60.0% to $26629.0 in 2026.
- Per Business Quant, the three latest BRGX Free Cash Flow figures stand at $26629.0 (Q1 2026), $66579.0 (Q4 2025), and -$77564.0 (Q3 2025).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Free Cash Flow (Qtr) |
|---|---|---|---|---|---|
| 1 | Veeva Systems | 31.81 Bn | 24.49 Bn | 662.02 Mn | 1.13 Bn |
| 2 | BrightSpring Health Services | 14.76 Bn | 13.86 Bn | 482.22 Mn | 101.40 Mn |
| 3 | Healthequity | 8.36 Bn | 8.10 Bn | 256.31 Mn | 81.60 Mn |
| 4 | Hinge Health | 5.91 Bn | 5.60 Bn | 154.23 Mn | 43.00 Mn |
| 5 | 10x Genomics | 5.89 Bn | 5.35 Bn | 106.18 Mn | 26.00 Mn |
| 6 | MiniMed | 4.45 Bn | 4.16 Bn | 480.00 Mn | -226.00 Mn |
| 7 | Waystar Holding | 4.41 Bn | 4.35 Bn | 216.84 Mn | 69.59 Mn |
| 8 | Doximity | 3.93 Bn | 3.18 Bn | 125.97 Mn | 116.17 Mn |
| 9 | Privia Health | 3.10 Bn | 2.68 Bn | - | -48.49 Mn |
| 10 | Bioregenx | 9.69 Mn | 9.65 Mn | 348,288.00 | 26,629.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 26,629.00 |
| Mar 31, 2026 | 26,629.00 |
| Dec 31, 2025 | 66,579.00 |
| Dec 31, 2025 | 66,579.00 |
| Sep 30, 2025 | -77,564.00 |
| Sep 30, 2025 | -77,564.00 |
| Jun 30, 2025 | 3,205.00 |
| Jun 30, 2025 | 3,205.00 |
| Mar 31, 2025 | 37,695.00 |
| Mar 31, 2025 | 37,695.00 |
| Dec 31, 2024 | -11,361.00 |
| Dec 31, 2024 | -11,361.00 |
| Sep 30, 2024 | -31,196.00 |
| Sep 30, 2024 | -31,196.00 |
| Jun 30, 2024 | -177,341.00 |
| Jun 30, 2024 | -177,341.00 |
| Mar 31, 2024 | -293,640.00 |
| Mar 31, 2024 | -293,640.00 |
| Dec 31, 2023 | -245,626.00 |
| Dec 31, 2023 | -245,626.00 |